Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-22

Clinical Trial Update: Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia [NA]

View source ↗

Summary

Clinical trial update on Erwinia asparaginase for patients with acute lymphoblastic leukemia after allergy to PEG-asparaginase; study status completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erwinia asparaginase (Erwinia asparaginase)

Snippet

Sponsor: Children's Oncology Group | Conditions: Adult Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia | NA | Status: COMPLETED | Results posted: 2014-08-22